 | • レポートコード：MRC2-11QY13578 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は副腎皮質がん治療のグローバル市場について調査・分析したレポートです。種類別（限局性副腎皮質がん、転移性副腎皮質がん）市場規模、用途別（病院、外来手術センター、診療所、がん研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別副腎皮質がん治療の競争状況、市場シェア ・世界の副腎皮質がん治療市場：種類別市場規模 2015年-2020年（限局性副腎皮質がん、転移性副腎皮質がん） ・世界の副腎皮質がん治療市場：種類別市場規模予測 2021年-2026年（限局性副腎皮質がん、転移性副腎皮質がん） ・世界の副腎皮質がん治療市場：用途別市場規模 2015年-2020年（病院、外来手術センター、診療所、がん研究所） ・世界の副腎皮質がん治療市場：用途別市場規模予測 2021年-2026年（病院、外来手術センター、診療所、がん研究所） ・北米の副腎皮質がん治療市場分析：米国、カナダ ・ヨーロッパの副腎皮質がん治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの副腎皮質がん治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の副腎皮質がん治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの副腎皮質がん治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：ArQule、EnGeneIC、Exelixis、Merck、Millendo Therapeutics、Orphagen Pharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Adrenocortical carcinoma (ACC) is a rare disease caused by cancerous growth in the adrenal cortex, which is the outer layer of the adrenal glands. The adrenal glands lie on top of the kidneys. They play a major role in the endocrine system, which is the system that produces and regulates hormones. The causes of primary adrenocortical carcinoma are unknown. However adrenocortical carcinoma can also be secondary cancer. A secondary cancer is what happens when another form of cancer spreads to the adrenal glands. Adrenocortical carcinoma can occur at any age, but there is a bimodal distribution with a first peak at childhood between 1–6 years old and the second peak in the fourth to the fifth decade of life. During the past decade, collaborative efforts have been made to improve the ACC treatment.
Some of the key factors that are driving the adrenocortical carcinoma treatment market are increasing the prevalence of cancer, rising government involvement, increasing funding from various government and non-government organizations. Also, ethical acceptance of adrenocortical carcinoma treatment and high unmet needs in some regions are driving the adrenocortical carcinoma treatment market. However, less awareness and high cost involved in treatment are restraining the global adrenocortical carcinoma treatment market. Also, the introduction of generic drugs in some countries is restraining the growth of adrenocortical carcinoma treatment market. Also, despite the high cost involved in R&D, pharmaceutical companies are showing increased interest in this field. This is expected to offer good potential for adrenocortical carcinoma treatment market.
Market Analysis and Insights: Global Adrenocortical Carcinoma Treatment Market
The global Adrenocortical Carcinoma Treatment market size is projected to reach US$ 545.6 million by 2026, from US$ 537 million in 2020, at a CAGR of 1.5%% during 2021-2026.
Global Adrenocortical Carcinoma Treatment Scope and Market Size
Adrenocortical Carcinoma Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Adrenocortical Carcinoma Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
ArQule
EnGeneIC
Exelixis
Merck
Millendo Therapeutics
Orphagen Pharmaceuticals
…
Market segment by Type, the product can be split into
Localized Adrenocortical Carcinoma
Metastatic Adrenocortical Carcinoma
Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Clinics
Cancer Research Institutes
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Adrenocortical Carcinoma Treatment Revenue
1.4 Market by Type
1.4.1 Global Adrenocortical Carcinoma Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Localized Adrenocortical Carcinoma
1.4.3 Metastatic Adrenocortical Carcinoma
1.5 Market by Application
1.5.1 Global Adrenocortical Carcinoma Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Clinics
1.5.5 Cancer Research Institutes
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Adrenocortical Carcinoma Treatment Market Perspective (2015-2026)
2.2 Global Adrenocortical Carcinoma Treatment Growth Trends by Regions
2.2.1 Adrenocortical Carcinoma Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Adrenocortical Carcinoma Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Adrenocortical Carcinoma Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Adrenocortical Carcinoma Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Adrenocortical Carcinoma Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Adrenocortical Carcinoma Treatment Players by Market Size
3.1.1 Global Top Adrenocortical Carcinoma Treatment Players by Revenue (2015-2020)
3.1.2 Global Adrenocortical Carcinoma Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Adrenocortical Carcinoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Adrenocortical Carcinoma Treatment Market Concentration Ratio
3.2.1 Global Adrenocortical Carcinoma Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Adrenocortical Carcinoma Treatment Revenue in 2019
3.3 Adrenocortical Carcinoma Treatment Key Players Head office and Area Served
3.4 Key Players Adrenocortical Carcinoma Treatment Product Solution and Service
3.5 Date of Enter into Adrenocortical Carcinoma Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Adrenocortical Carcinoma Treatment Historic Market Size by Type (2015-2020)
4.2 Global Adrenocortical Carcinoma Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Adrenocortical Carcinoma Treatment Market Size by Application (2015-2020)
5.2 Global Adrenocortical Carcinoma Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Adrenocortical Carcinoma Treatment Market Size (2015-2020)
6.2 Adrenocortical Carcinoma Treatment Key Players in North America (2019-2020)
6.3 North America Adrenocortical Carcinoma Treatment Market Size by Type (2015-2020)
6.4 North America Adrenocortical Carcinoma Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Adrenocortical Carcinoma Treatment Market Size (2015-2020)
7.2 Adrenocortical Carcinoma Treatment Key Players in Europe (2019-2020)
7.3 Europe Adrenocortical Carcinoma Treatment Market Size by Type (2015-2020)
7.4 Europe Adrenocortical Carcinoma Treatment Market Size by Application (2015-2020)
8 China
8.1 China Adrenocortical Carcinoma Treatment Market Size (2015-2020)
8.2 Adrenocortical Carcinoma Treatment Key Players in China (2019-2020)
8.3 China Adrenocortical Carcinoma Treatment Market Size by Type (2015-2020)
8.4 China Adrenocortical Carcinoma Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Adrenocortical Carcinoma Treatment Market Size (2015-2020)
9.2 Adrenocortical Carcinoma Treatment Key Players in Japan (2019-2020)
9.3 Japan Adrenocortical Carcinoma Treatment Market Size by Type (2015-2020)
9.4 Japan Adrenocortical Carcinoma Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Adrenocortical Carcinoma Treatment Market Size (2015-2020)
10.2 Adrenocortical Carcinoma Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Adrenocortical Carcinoma Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Adrenocortical Carcinoma Treatment Market Size by Application (2015-2020)
11 India
11.1 India Adrenocortical Carcinoma Treatment Market Size (2015-2020)
11.2 Adrenocortical Carcinoma Treatment Key Players in India (2019-2020)
11.3 India Adrenocortical Carcinoma Treatment Market Size by Type (2015-2020)
11.4 India Adrenocortical Carcinoma Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Adrenocortical Carcinoma Treatment Market Size (2015-2020)
12.2 Adrenocortical Carcinoma Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Adrenocortical Carcinoma Treatment Market Size by Type (2015-2020)
12.4 Central & South America Adrenocortical Carcinoma Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 ArQule
13.1.1 ArQule Company Details
13.1.2 ArQule Business Overview
13.1.3 ArQule Adrenocortical Carcinoma Treatment Introduction
13.1.4 ArQule Revenue in Adrenocortical Carcinoma Treatment Business (2015-2020))
13.1.5 ArQule Recent Development
13.2 EnGeneIC
13.2.1 EnGeneIC Company Details
13.2.2 EnGeneIC Business Overview
13.2.3 EnGeneIC Adrenocortical Carcinoma Treatment Introduction
13.2.4 EnGeneIC Revenue in Adrenocortical Carcinoma Treatment Business (2015-2020)
13.2.5 EnGeneIC Recent Development
13.3 Exelixis
13.3.1 Exelixis Company Details
13.3.2 Exelixis Business Overview
13.3.3 Exelixis Adrenocortical Carcinoma Treatment Introduction
13.3.4 Exelixis Revenue in Adrenocortical Carcinoma Treatment Business (2015-2020)
13.3.5 Exelixis Recent Development
13.4 Merck
13.4.1 Merck Company Details
13.4.2 Merck Business Overview
13.4.3 Merck Adrenocortical Carcinoma Treatment Introduction
13.4.4 Merck Revenue in Adrenocortical Carcinoma Treatment Business (2015-2020)
13.4.5 Merck Recent Development
13.5 Millendo Therapeutics
13.5.1 Millendo Therapeutics Company Details
13.5.2 Millendo Therapeutics Business Overview
13.5.3 Millendo Therapeutics Adrenocortical Carcinoma Treatment Introduction
13.5.4 Millendo Therapeutics Revenue in Adrenocortical Carcinoma Treatment Business (2015-2020)
13.5.5 Millendo Therapeutics Recent Development
13.6 Orphagen Pharmaceuticals
13.6.1 Orphagen Pharmaceuticals Company Details
13.6.2 Orphagen Pharmaceuticals Business Overview
13.6.3 Orphagen Pharmaceuticals Adrenocortical Carcinoma Treatment Introduction
13.6.4 Orphagen Pharmaceuticals Revenue in Adrenocortical Carcinoma Treatment Business (2015-2020)
13.6.5 Orphagen Pharmaceuticals Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Adrenocortical Carcinoma Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Adrenocortical Carcinoma Treatment Revenue
Table 3. Ranking of Global Top Adrenocortical Carcinoma Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Adrenocortical Carcinoma Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Localized Adrenocortical Carcinoma
Table 6. Key Players of Metastatic Adrenocortical Carcinoma
Table 7. Global Adrenocortical Carcinoma Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Adrenocortical Carcinoma Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Adrenocortical Carcinoma Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Adrenocortical Carcinoma Treatment Market Share by Regions (2015-2020)
Table 11. Global Adrenocortical Carcinoma Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Adrenocortical Carcinoma Treatment Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Adrenocortical Carcinoma Treatment Market Growth Strategy
Table 17. Main Points Interviewed from Key Adrenocortical Carcinoma Treatment Players
Table 18. Global Adrenocortical Carcinoma Treatment Revenue by Players (2015-2020) (Million US$)
Table 19. Global Adrenocortical Carcinoma Treatment Market Share by Players (2015-2020)
Table 20. Global Top Adrenocortical Carcinoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adrenocortical Carcinoma Treatment as of 2019)
Table 21. Global Adrenocortical Carcinoma Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Adrenocortical Carcinoma Treatment Product Solution and Service
Table 24. Date of Enter into Adrenocortical Carcinoma Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Adrenocortical Carcinoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 27. Global Adrenocortical Carcinoma Treatment Market Size Share by Type (2015-2020)
Table 28. Global Adrenocortical Carcinoma Treatment Revenue Market Share by Type (2021-2026)
Table 29. Global Adrenocortical Carcinoma Treatment Market Size Share by Application (2015-2020)
Table 30. Global Adrenocortical Carcinoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 31. Global Adrenocortical Carcinoma Treatment Market Size Share by Application (2021-2026)
Table 32. North America Key Players Adrenocortical Carcinoma Treatment Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Adrenocortical Carcinoma Treatment Market Share (2019-2020)
Table 34. North America Adrenocortical Carcinoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. North America Adrenocortical Carcinoma Treatment Market Share by Type (2015-2020)
Table 36. North America Adrenocortical Carcinoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. North America Adrenocortical Carcinoma Treatment Market Share by Application (2015-2020)
Table 38. Europe Key Players Adrenocortical Carcinoma Treatment Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Adrenocortical Carcinoma Treatment Market Share (2019-2020)
Table 40. Europe Adrenocortical Carcinoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Adrenocortical Carcinoma Treatment Market Share by Type (2015-2020)
Table 42. Europe Adrenocortical Carcinoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Adrenocortical Carcinoma Treatment Market Share by Application (2015-2020)
Table 44. China Key Players Adrenocortical Carcinoma Treatment Revenue (2019-2020) (Million US$)
Table 45. China Key Players Adrenocortical Carcinoma Treatment Market Share (2019-2020)
Table 46. China Adrenocortical Carcinoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. China Adrenocortical Carcinoma Treatment Market Share by Type (2015-2020)
Table 48. China Adrenocortical Carcinoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. China Adrenocortical Carcinoma Treatment Market Share by Application (2015-2020)
Table 50. Japan Key Players Adrenocortical Carcinoma Treatment Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Adrenocortical Carcinoma Treatment Market Share (2019-2020)
Table 52. Japan Adrenocortical Carcinoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Adrenocortical Carcinoma Treatment Market Share by Type (2015-2020)
Table 54. Japan Adrenocortical Carcinoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Adrenocortical Carcinoma Treatment Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Adrenocortical Carcinoma Treatment Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Adrenocortical Carcinoma Treatment Market Share (2019-2020)
Table 58. Southeast Asia Adrenocortical Carcinoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Adrenocortical Carcinoma Treatment Market Share by Type (2015-2020)
Table 60. Southeast Asia Adrenocortical Carcinoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Adrenocortical Carcinoma Treatment Market Share by Application (2015-2020)
Table 62. India Key Players Adrenocortical Carcinoma Treatment Revenue (2019-2020) (Million US$)
Table 63. India Key Players Adrenocortical Carcinoma Treatment Market Share (2019-2020)
Table 64. India Adrenocortical Carcinoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. India Adrenocortical Carcinoma Treatment Market Share by Type (2015-2020)
Table 66. India Adrenocortical Carcinoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. India Adrenocortical Carcinoma Treatment Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Adrenocortical Carcinoma Treatment Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Adrenocortical Carcinoma Treatment Market Share (2019-2020)
Table 70. Central & South America Adrenocortical Carcinoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Adrenocortical Carcinoma Treatment Market Share by Type (2015-2020)
Table 72. Central & South America Adrenocortical Carcinoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Adrenocortical Carcinoma Treatment Market Share by Application (2015-2020)
Table 74. ArQule Company Details
Table 75. ArQule Business Overview
Table 76. ArQule Product
Table 77. ArQule Revenue in Adrenocortical Carcinoma Treatment Business (2015-2020) (Million US$)
Table 78. ArQule Recent Development
Table 79. EnGeneIC Company Details
Table 80. EnGeneIC Business Overview
Table 81. EnGeneIC Product
Table 82. EnGeneIC Revenue in Adrenocortical Carcinoma Treatment Business (2015-2020) (Million US$)
Table 83. EnGeneIC Recent Development
Table 84. Exelixis Company Details
Table 85. Exelixis Business Overview
Table 86. Exelixis Product
Table 87. Exelixis Revenue in Adrenocortical Carcinoma Treatment Business (2015-2020) (Million US$)
Table 88. Exelixis Recent Development
Table 89. Merck Company Details
Table 90. Merck Business Overview
Table 91. Merck Product
Table 92. Merck Revenue in Adrenocortical Carcinoma Treatment Business (2015-2020) (Million US$)
Table 93. Merck Recent Development
Table 94. Millendo Therapeutics Company Details
Table 95. Millendo Therapeutics Business Overview
Table 96. Millendo Therapeutics Product
Table 97. Millendo Therapeutics Revenue in Adrenocortical Carcinoma Treatment Business (2015-2020) (Million US$)
Table 98. Millendo Therapeutics Recent Development
Table 99. Orphagen Pharmaceuticals Company Details
Table 100. Orphagen Pharmaceuticals Business Overview
Table 101. Orphagen Pharmaceuticals Product
Table 102. Orphagen Pharmaceuticals Revenue in Adrenocortical Carcinoma Treatment Business (2015-2020) (Million US$)
Table 103. Orphagen Pharmaceuticals Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Adrenocortical Carcinoma Treatment Market Share by Type: 2020 VS 2026
Figure 2. Localized Adrenocortical Carcinoma Features
Figure 3. Metastatic Adrenocortical Carcinoma Features
Figure 4. Global Adrenocortical Carcinoma Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Ambulatory Surgical Centers Case Studies
Figure 7. Clinics Case Studies
Figure 8. Cancer Research Institutes Case Studies
Figure 9. Adrenocortical Carcinoma Treatment Report Years Considered
Figure 10. Global Adrenocortical Carcinoma Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Adrenocortical Carcinoma Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Adrenocortical Carcinoma Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Adrenocortical Carcinoma Treatment Market Share by Players in 2019
Figure 15. Global Top Adrenocortical Carcinoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adrenocortical Carcinoma Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Adrenocortical Carcinoma Treatment Revenue in 2019
Figure 17. North America Adrenocortical Carcinoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Adrenocortical Carcinoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Adrenocortical Carcinoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Adrenocortical Carcinoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Adrenocortical Carcinoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Adrenocortical Carcinoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Adrenocortical Carcinoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
尿路上皮がん治療の世界市場（～2026年） Urothelial carcinoma is also called as transitional cell carcinoma which is a cancerous tumor of the bladder that can spread to other parts of the body. These are also called as malignant tumors. This tumor can start at any part of the urinary tract. People with bladder cancer may also have similar …- 頭頸部扁平上皮がん (HNSCC)治療の世界市場（～2026年） Head and neck cancer usually occurs in the squamous cells present inside the mouth, nose and throat. These squamous cells are usually known as squamous cell carcinoma of the head and neck. Market Analysis and Insights: Global Squamous Cell Carcinoma of the Head and Neck Treatment Market The global S…
- 結腸・直腸がんの世界市場（～2026年） Market Analysis and Insights: Global Colon & Rectal Carcinoma Market The global Colon & Rectal Carcinoma market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Colon & Rectal Carcinoma Scope and Market Size Colon & Rectal Car…
- 胸腺癌治療の世界市場（～2026年） Market Analysis and Insights: Global Thymic Carcinoma Treatment Market The global Thymic Carcinoma Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Thymic Carcinoma Treatment Scope and Market Size Thymic Carci…
- 尿路上皮がん診断の世界市場（～2026年） Urothelial Carcinoma or Transitional Cell Carcinoma encompasses cancer in different parts of urinary tract like kidney, bladder, ureters, and renal pelvis. The increasing trends of cigarette smoking is increasing the chances of urothelial carcinoma manifold. Market Analysis and Insights: Global Urot…